VITA 34 AG (0NLV.L)

3,9200 -1,0600 (-21,29%) Alla chiusura: 08:04AM GMT

VITA 34 AG

Deutscher Platz 5a
Leipzig 04103
Germany
49 341 48792 40
https://www.vita34.de

Settore/i: 
Settore: 
Impiegati a tempo pieno: 815

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Jakub Julian Baran	Chairman of the Management Board & CEO	N/D	N/D	N/D
Mr. Tomasz Franciszek Baran	Vice President of the Management Board & Chief Commercial Officer	N/D	N/D	N/D
Mr. Dirk Plaga	CFO & Member of Management Board	N/D	N/D	1965
Santiago Luengo	Managing Director of Secuvita	N/D	N/D	N/D

Gli importi risalgono al giorno e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.

Descrizione

VITA 34 AG engages in the collection, processing, and cryopreservation of stem cells from umbilical cord blood and tissue in Germany, Poland, Portugal, and internationally. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces viral vectors and CAR-T cells. The company manufactures advanced therapy medicinal products for third parties. In addition, it offers a range of products for long-term storage of biological material obtained at birth, as well as placental blood or umbilical cord tissue or placenta tissue. Further, the company provides sperm banking services for freezing sperm; adipose tissue banking services as a source of mesenchymal stem cells and stromal vascular fraction; medical consultations and non-diagnostic ultrasound examination services; and other contract manufacturing services for classical transplantations or cell and gene therapies. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany.

Governance aziendale

L'ISS Governance QualityScore di VITA 34 AG al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.